The results of CDH3 expression analysis demonstrated that it was significantly decreased in tissue from patients with PCa compared to BPH (0.52 ± 0.12; mean ± s.e.m.; p = 0.018), in full coherence with our observation in uEVs (Figure 3A). The gene discussed is CDH3; the disease is benign prostatic hyperplasia.